Patient ambassador support in newly diagnosed patients with acute leukemia during treatment: a feasibility study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Patient ambassador support in newly diagnosed patients with acute leukemia during treatment: a feasibility study. / Norskov, Kristina Holmegaard; Overgaard, Dorthe; Boesen, Jannie; Struer, Anne; El-Azem, Sarah Elke Weber Due; Tolver, Anders; Lomborg, Kirsten; Kjeldsen, Lars; Jarden, Mary.
In: Supportive Care in Cancer, Vol. 29, No. 6, 2021, p. 3077 - 3089.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Patient ambassador support in newly diagnosed patients with acute leukemia during treatment: a feasibility study
AU - Norskov, Kristina Holmegaard
AU - Overgaard, Dorthe
AU - Boesen, Jannie
AU - Struer, Anne
AU - El-Azem, Sarah Elke Weber Due
AU - Tolver, Anders
AU - Lomborg, Kirsten
AU - Kjeldsen, Lars
AU - Jarden, Mary
PY - 2021
Y1 - 2021
N2 - PurposeThis study investigated the feasibility of patient ambassador support in newly diagnosed patients with acute leukemia during treatment.MethodsA multicenter single-arm feasibility study that included patients newly diagnosed with acute leukemia (n = 36) and patient ambassadors previously treated for acute leukemia (n = 25). Prior to the intervention, all patient ambassadors attended a 6-h group training program. In the intervention, patient ambassadors provided 12 weeks of support for patients within 2 weeks of being diagnosed. Outcome measures included feasibility (primary outcome), safety, anxiety, and depression measured by the Hospital Anxiety and Depression Scale, quality of life by the Functional Assessment of Cancer Therapy–Leukemia and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, and symptom burden by MD Anderson Symptom Inventory, the Patient Activation Measure, and the General Self-Efficacy Scale.ResultsPatient ambassador support was feasible and safe in this population. Patients and patient ambassadors reported high satisfaction with the individually adjusted support, and patients improved in psychosocial outcomes over time. Patient ambassadors maintained their psychosocial baseline level, with no adverse events, and used the available support to exchange experiences with other patient ambassadors and to manage challenges.ConclusionThe patient ambassador support program is feasible and has the potential to be a new model of care incorporated in the hematology clinical care setting, creating an active partnership between patients and former patients. This may strengthen the existing supportive care services for patients with acute leukemia.
AB - PurposeThis study investigated the feasibility of patient ambassador support in newly diagnosed patients with acute leukemia during treatment.MethodsA multicenter single-arm feasibility study that included patients newly diagnosed with acute leukemia (n = 36) and patient ambassadors previously treated for acute leukemia (n = 25). Prior to the intervention, all patient ambassadors attended a 6-h group training program. In the intervention, patient ambassadors provided 12 weeks of support for patients within 2 weeks of being diagnosed. Outcome measures included feasibility (primary outcome), safety, anxiety, and depression measured by the Hospital Anxiety and Depression Scale, quality of life by the Functional Assessment of Cancer Therapy–Leukemia and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, and symptom burden by MD Anderson Symptom Inventory, the Patient Activation Measure, and the General Self-Efficacy Scale.ResultsPatient ambassador support was feasible and safe in this population. Patients and patient ambassadors reported high satisfaction with the individually adjusted support, and patients improved in psychosocial outcomes over time. Patient ambassadors maintained their psychosocial baseline level, with no adverse events, and used the available support to exchange experiences with other patient ambassadors and to manage challenges.ConclusionThe patient ambassador support program is feasible and has the potential to be a new model of care incorporated in the hematology clinical care setting, creating an active partnership between patients and former patients. This may strengthen the existing supportive care services for patients with acute leukemia.
KW - Peer support
KW - Patient ambassador
KW - Acute leukemia
KW - Supportive care
KW - Feasibility
KW - Psychosocial
U2 - 10.1007/s00520-020-05819-w
DO - 10.1007/s00520-020-05819-w
M3 - Journal article
C2 - 33051828
VL - 29
SP - 3077
EP - 3089
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
SN - 0941-4355
IS - 6
ER -
ID: 250603945